Rare diseases
Investigational molecules
Locations
353 conditions with trials, the busiest first
844 trials across Europe, recruiting first
Study on the Long-Term Safety and Effectiveness of Nemolizumab for Patients with Prurigo Nodularis
AustriaStudy on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
AustriaStudy of Obexelimab Treatment for Adults with Systemic Lupus Erythematosus (SLE)
BelgiumStudy on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines
BelgiumStudy on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines
BulgariaStudy on the Effectiveness and Safety of Vibozilimod for Adults with Moderate to Severe Plaque Psoriasis
EstoniaStudy on the Effects of GSK1070806 Injection in Adults with Moderate to Severe Atopic Dermatitis
BulgariaStudy on the Effectiveness and Safety of ANB032, Betamethasone Dipropionate, and Hydrocortisone for Patients with Moderate to Severe Atopic Dermatitis
CzechiaStudy of Ritlecitinib (50 mg and 100 mg daily) compared to placebo in adults with nonsegmental vitiligo
BelgiumStudy on the Effects of Upadacitinib in Adults and Adolescents with Non-Segmental Vitiligo Eligible for Systemic Treatment
BelgiumStudy on the Effectiveness of Povorcitinib for Adults with Nonsegmental Vitiligo
BulgariaStudy on the Effectiveness of Povorcitinib for Adults with Nonsegmental Vitiligo
BelgiumThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
